http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018056902-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N55-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30882594213ff0996e71f0771814120c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_755bd377855e87c5992832eb2313a958
publicationDate 2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018056902-A1
titleOfInvention Imidazolium compounds, methods of synthesis and uses thereof
abstract The present invention generally relates to a non-linear imidazolium compound of Formula (I), comprising a planar or stereo core structure. In addition, the present invention relates to the method of preparing the imidazolium compound as disclosed herein. Advantageously, the imidazolium compound of the present disclosure may demonstrate antimicrobial properties. The present invention also relates to the therapeutic and non-therapeutic use of the imidazolium compound as disclosed herein.
priorityDate 2016-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012149523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016043660-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID374631330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226937086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415786518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID530258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226668073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226606932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142310466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID286729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134377348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226794529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410905470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226500186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226666775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4589352

Total number of triples: 51.